Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Christian Draisbach

Piper Sandler Companies (NYSE: PIPR) has announced the appointment of Christian Draisbach as managing director to their healthcare investment banking team.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/07/2025 - 09:01 AM EDT

NEW YORK--(BUSINESS WIRE)-- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Christian Draisbach as a managing director to the healthcare investment banking team. Draisbach will be responsible for advising and supporting clients in the biopharma sector.

“We are excited for Christian to join our healthcare investment banking team. Christian brings 20 years of experience advising biopharma executives and boards through the lifecycle of their business on complex strategic initiatives and mergers, acquisitions, divestitures and partnership transactions in the U.S., Europe and Asia. During his career, Christian has advised on some of the most relevant strategic transactions in the biopharma sector globally. His transaction experience spans the spectrum from early development-stage private transactions to some of the largest and highest-profile public deals. Adding Christian’s experience and network of relationships to our existing platform will drive the Piper Sandler biopharma M&A business both in the U.S. and abroad,” said Peter Day, managing director and global group head of healthcare investment banking at Piper Sandler.

Draisbach joins the firm from Centerview Partners where he was a managing director primarily focused on clients in the life sciences and broader healthcare sectors. Earlier in his career, Mr. Draisbach worked at Morgan Stanley in the mergers and acquisitions and financial sponsor coverage groups based in the U.S., Europe and Asia. Draisbach earned a M.Sc. in finance from the London School of Economics & Political Science (U.K.) and a B.A. in business administration from the University of St. Gallen (Switzerland).

“Piper Sandler has a well-earned reputation as a leading investment banking advisory firm in the healthcare sector and I’m excited to join at this pivotal inflection point in its growth strategy. Being at the forefront of providing intellectually rigorous and independent strategic advice, the firm has a long track record of building some of the most successful client-centric practices anchored in deep industry expertise. I look forward to working alongside this talented team and to build on its success serving clients in the biopharma sector in the U.S. and internationally,” said Draisbach.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, authorized and regulated by BaFin as a tied agent of AHP Capital Management GmbH; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X